Trump to see the 'magic' behind Covid-19 vaccine effort during NC visit

The purpose of President Donald Trump’s upcoming visit to a North Carolina biotech is simple: To see where the 'magic' happens, according to one of his top aides. If all goes as expected, the drug component Morrisville-based Fujifilm Diosynth Biotechnologies is producing for Novavax (NASDAQ: NVAX) will be used in a phase 3 Covid-19 vaccine trial with up to 30,000 subjects. “No vaccine has ever been produced and distributed in the time that we are trying to do it in,” Peter Navarro, a top…